Regencell Bioscience (RGC) Appoints New Independent Auditor

Regencell Bioscience Holdings (RGC) has appointed a new independent auditor, enhancing its financial oversight and compliance. This move underscores the company's commitment to adhering to regulatory standards and improving investor confidence. No specific financial data or performance metrics were reported in this announcement, but such appointments may influence market perception. Investors often view strong financial governance as a positive sign for future stability.